SGMT

Conviction 83HealthcareScan · Fri, Jun 26, 2026

SGMT$7.04+2.55%

ResistanceSupportVol 14

Vol MA14 1.37M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Sagimet Biosciences Inc.PHARMACEUTICAL PREPARATIONSwww.sagimet.com ↗

Price7.04

Change+2.55%

Gap+0.44%

Rel volume5.35×

Avg volume1.16M

Avg $ vol7.87M

SMA 206.77

SMA 507.03

SMA 2006.54

Price vs 50+0.01%

Price vs 200+7.58%

MA stackbullish

50/200 cross—

Supertrenddown · 7.49

RSI (14)55

MACD hist0.05

MACD crossbull · 4d

Stoch %K / %D72 / 64

ADX (14)13

+DI / −DI24 / 18

RSI divergence—

MACD divergenceBullish

ATR %+5.41%

ADR %5.01%

52w high10.24

52w low4.55

From 52w high-31.30%

Above 52w low+54.62%

New 52w highNo

SqueezeOff

Bollinger width16.74%

%B0.73

Donchian pos67.95%

Donchian high7.41

Donchian low6.24

AVWAP (52w high)7.28

vs AVWAP high-3.31%

AVWAP (52w low)7.63

vs AVWAP low-7.78%

OBV trendFlat

Chaikin MF (20)-0.09

Today vs 20d5.35×

Avg vol (14d)1.37M

Avg vol (20d)1.16M

Avg $ vol (20d)7.87M

Market cap—

RS 3m (vs SPY)+36.69%

RS 6m (vs SPY)+2.71%

RS line new highNo

Trend template4/8

Technical rank59.4

1 week+5.31%

1 month-2.56%

3 months+37.67%

6 months+17.05%

1 year-21.92%

YTD+17.45%

P/E-4.12

P/B2.05

P/S105.06

P/FCF—

EPS-1.58

Div yield—

ROE-49.81%

ROA-47.36%

Debt/Eq—

Current20.34

EV/EBITDA—

Gross margin—

Net margin—

Rev growth0.00%

EPS growth-12.01%

Price target26.09

Target upside280.88%

Analyst ratingBuy

Institutional23.96%

Ent. value173.5M

Revenue2M

Net income-10.65M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out32.02M

Employees16

ListedFri, Jul 14, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction83 / 100

Pattern quality—

Tech rank59.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.98

Support6.28

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SGMT

All disclosures →

No recent disclosed trades by Congress in SGMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SGMT · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Happel David President & CEO · Stock Option (Right to Buy) · 2026-05-28	Grant	300K	$0	2026-05-28	2026-06-01
Rozek Elizabeth Chief Legal & Admin. Officer · Stock Option (Right to Buy) · 2026-05-28	Grant	100K	$0	2026-05-28	2026-06-01
Grauer Andreas Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-28	Grant	35K	$0	2026-05-28	2026-06-01
Chauche Thierry Chief Financial Officer · Stock Option (Right to Buy) · 2026-05-28	Grant	50K	$0	2026-05-28	2026-06-01
Grauer Andreas Chief Medical Officer · Stock Option (Right to Buy) · 2026-04-20	Grant	264.76K	$0	2026-04-20	2026-05-14

SEC filings

EDGAR filings in SGMT · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.